 | Yahoo! Health - My Alerts - Edit Alert |
| Thursday, Nov 29, 2012 05:03 PM EST | |
| FDA approves Exelixis' cabozantinib for thyroid cancer reuters.com Thu, 29 Nov, 2012 01:55 PM PST WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Thursday approved Exelixis Inc's cabozantinib as a treatment for medullary thyroid cancer that has spread to other parts of the body. Cabozantinib, the company's lead product candidate, is an oral drug designed to limit blood supply to tumors as well as block two segments of a pathway used by cancer cells to grow and spread. The FDA ... Study finds herbalists at higher urinary cancer risk reuters.com Thu, 29 Nov, 2012 01:09 PM PST NEW YORK (Reuters Health) - A small new study from Taiwan links a widely banned substance traditionally used in Chinese medicine to an elevated risk for kidney and bladder cancers among professional herbalists. Herbs, such as fang chi, that contain the plant-derived aristolochic acid, are known to cause cancer as well as kidney failure, and the current study suggests that working with these ... Algunas mujeres se ven superadas por cantidad opciones terapéuticas para cáncer reuters.com Thu, 29 Nov, 2012 11:12 AM PST NUEVA YORK (Reuters Health) - Más de una de cada cincomujeres con cáncer de mama temprano dijo que se le atribuÃademasiada responsabilidad en la decisión terapéutica y eran máspropensas a arrepentirse de las decisiones tomadas, señala unnuevo estudio. Para los autores, esto no quiere decir que las mujeres nodeberÃan recibir toda la información sobre las opcionesterapéuticas, sino que los médicos ... | |
|
No comments:
Post a Comment